LATS1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemLATS1 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-35797
Gene NameLATS, large tumor suppressor, homolog 1 (Drosophila)
Quantity10 µM
Specieshuman
NCBI Full Gene Namelarge tumor suppressor kinase 1
NCBI Gene AliasesWARTS, wts
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1Biochemical and biophysical research communicationsNovember 26, 2021Mao J, Qiu H, Guo L.

(2) Chimeric RNA-binding protein-based killing switch targeting hepatocellular carcinoma cellsMolecular therapy. Nucleic acidsSeptember 3, 2021Yang J, Ding S.mV/cm2. siRNAs for gene knockdown siRNAs used to knockdown AFP (sc-88864), YAP1 (sc-38637), LATS1 (sc-35797), and MOB1B (sc270319) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). These siRNAs

(3) LATS1 Regulates Mixed-Lineage Kinase 3 (MLK3) Subcellular Localization and MLK3-Mediated Invasion in Ovarian Epithelial CellsMolecular and cellular biologyJune 23, 2021Kasturirangan S, Mehdi B, Chadee DN.

(4) Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular CarcinomaMolecular therapy oncolyticsJune 26, 2020Han X, Yang J, Zeng F, Weng J, Zhang Y, Peng Q, Shen L, Ding S, Liu K, Gao Y.RNAs (siRNAs) was used to knockdown YAP1 (sc-38637, Santa Cruz Biotechnology, Dallas, TX, USA), LATS1 (sc-35797, Santa Cruz Biotechnology, Dallas, TX, USA), MOB1B (sc-88864, Santa Cruz Biotechnology, Dallas, Texas),

(5) Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor ReceptorJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerOctober 1, 2019Rong X, Liang Y, Han Q, Zhao Y, Jiang G, Zhang X, Lin X, Liu Y, Zhang Y, Han X, et al.

(6) SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of PatientsThe journal of histochemistry and cytochemistry : official journal of the Histochemistry SocietyJanuary 1, 2019Yang C, Xu W, Meng X, Zhou S, Zhang M, Cui D.pCMV6-ddk-mycSCC-S2 (RC202729) were purchased from Origene (Rockville, MD). SCC-S2-siRNA (sc-76700), LATS 1-siRNA (sc-35797), β-catenin-siRNA (sc-29209), and NC-siRNA (sc-37007) were purchased from Santa Cruz Biotechnology.

(7) FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxisFASEB journal : official publication of the Federation of American Societies for Experimental BiologyFebruary 1, 2018Lachowski D, Cortes E, Robinson B, Rice A, Rombouts K, Del Río Hernández AE.

(8) A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo PathwayCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2018Bao L, Yuan L, Li P, Bu Q, Guo A, Zhang H, Cui N, Liu B.cell lines construction Lentiviral shRNAs targeting human LATS1/2 were obtained from Santa Cruz (Cat # sc-35797 and Cat # sc-37444). A scramble non-targeting shRNA was used as control. FUS CDS sequences were inserted

(9) WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signalingOncoTargets and therapyJanuary 1, 2018Han Q, Kremerskothen J, Lin X, Zhang X, Rong X, Zhang D, Wang E.pGPU6-shWWC3-1-RFP, and pGPU6-shWWC3-2-RFP were purchased from GenePharma (Shanghai, China). LATS1 siRNA (sc-35797), YAP siRNA (sc-38637), and control siRNA (sc-37007) were purchased from Santa Cruz Biotechnology Inc.

(10) Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatinMedical oncology (Northwood, London, England)November 22, 2017Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, et al.

(11) YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acidOncotargetAugust 9, 2016Xu G, Wang J, Wu F, Wang N, Zhou W, Wang Q, Pan W, Ao G, Yang J.

(12) Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancerTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineJuly 1, 2014Lin XY, Zhang XP, Wu JH, Qiu XS, Wang EH.

Be the First to Write a Review!

LATS1 siRNA (h)

LATS1 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (12)

Reviews

LATS1 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map